From the publishers of JADPRO

Renal Cell Carcinoma Resource Center

Advertisement

Comparison of financial toxicity among patients with non-metastatic versus metastatic renal cell carcinoma

Last Updated: Thursday, May 2, 2024

The Kidney Cancer Research Alliance conducted a survey with 1062 responders to determine how financial toxicity impacts quality of life in patients with localized RCC versus patients with metastatic RCC. Results showed that RCC imposes financial hardship on patients, with those younger patients with a higher NCCN distress score and a shorter time since diagnosis more likely to suffer financial hardships.  

Journal of Clinical Oncology
Advertisement
News & Literature Highlights
Advertisement
Advertisement